Skip to search formSkip to main contentSkip to account menu

Exanta

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
For decades, the standards of antithrombotic therapy have been heparin and coumarin compounds, primarily warfarin (1). Other… 
Review
2004
Review
2004
It is rare for any drug introduced more than 50 years ago to remain unsurpassed today; yet the oral prevention and treatment of… 
Review
2004
Review
2004
Ximelagatran (Exanta™, AstraZeneca) is a novel oral direct thrombin inhibitor that inhibits the final step in the coagulation… 
Review
2003
Review
2003
2003
2003
  • O. Glynn
  • International journal of clinical practice
  • 2003
  • Corpus ID: 36614347
The phase III trial EXPRESS was a randomised, double-blind comparison of two anticoagulant therapies used as prophylaxis against…